Vergleichsstudie
1-β-D-Arabinofuranosylcytosine-Phospholipid Conjugates As Prodrugs of Ara-C
Cancer Drug Delivery · 1984
DOI: 10.1089/cdd.1984.1.181 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Drug Delivery, 1984. Verfasst von C I Hong und 7 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnimalsCytarabineDrug Evaluation, PreclinicalIsomerismLeukemia L1210MiceMice, Inbred DBAMice, Inbred StrainsStructure-Activity Relationship
Substanzen
Cytarabine
Förderung
- NCI NIH HHS
Zitieren
APA
Hong, C. I., An, S. H., Buchheit, D. J., Nechaev, A., Kirisits, A. J., West, C. R., Ryu, E. K., & MacCoss, M. (1984). 1-β-D-Arabinofuranosylcytosine-Phospholipid Conjugates As Prodrugs of Ara-C. Cancer Drug Delivery. https://doi.org/10.1089/cdd.1984.1.181
Vancouver
Hong CI, An SH, Buchheit DJ, Nechaev A, Kirisits AJ, West CR, et al. 1-β-D-Arabinofuranosylcytosine-Phospholipid Conjugates As Prodrugs of Ara-C. Cancer Drug Delivery. 1984. doi:10.1089/cdd.1984.1.181
BibTeX
@article{Hong1984,
author = {Hong, C I and An, S H and Buchheit, D J and Nechaev, A and Kirisits, A J and West, C R and Ryu, E K and MacCoss, M},
title = {1-β-D-Arabinofuranosylcytosine-Phospholipid Conjugates As Prodrugs of Ara-C},
journal = {Cancer Drug Delivery},
year = {1984},
doi = {10.1089/cdd.1984.1.181}
}
EUVIMED